Skip to main content
Clinical Trials/ISRCTN11274834
ISRCTN11274834Completed未知

Providing open-label placebos remotely – a randomized controlled trial in allergic rhinitis

niversity of Koblenz and Landau0 sites54 target enrollmentStarted: May 4, 2021Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
54

Study Overview

Brief Summary

2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33705475/ (added 23/08/2022)

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
All

Inclusion Criteria

  • 1. Diagnosed allergic rhinitis
  • 2. At least 18 years old
  • 3. Sufficient German language skills

Exclusion Criteria

  • 1. Pregnancy
  • 2. Diabetes
  • 3. Any mental or neurological illness
  • 4. Lactose intolerance

Investigators

Sponsor
niversity of Koblenz and Landau

Similar Trials

Openly prescribed placebos to reduce... | Clinical Trial